The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan

Sponsor
Taipei Veterans General Hospital, Taiwan (Other)
Overall Status
Unknown status
CT.gov ID
NCT02663063
Collaborator
(none)
494
1
2
10
49.3

Study Details

Study Description

Brief Summary

The study aims to explore the effects of silver spike point (SSP) treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients.

Condition or Disease Intervention/Treatment Phase
  • Device: SSP treatment
N/A

Detailed Description

The study aims to explore the effects of silver spike point treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients. We will conducted a pilot study to evaluate the effects on different symptoms and then a prospective study will be conducted after validation of major effects.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
494 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan-The Second and Third Year Project.
Study Start Date :
Dec 1, 2015
Anticipated Primary Completion Date :
Oct 1, 2016
Anticipated Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: SSP treatment group

Case on SSP treatment

Device: SSP treatment
SSP treatment 5 times a week

Sham Comparator: Non-SSP treatment group

Sham SSP treatment

Device: SSP treatment
SSP treatment 5 times a week

Outcome Measures

Primary Outcome Measures

  1. Symptom severity score [One week after treatment]

    Questionnaire for evaluating the severity of symptoms

Secondary Outcome Measures

  1. Quality of life [One week after treatment]

    Questionnaire for evaluating quality of life

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cancer patients

  • Competent with clear consciousness

  • With symptoms of pain, breathlessness, nause/vomiting, dry mouth, generalized discomfort

  • Expected life span of at least 1 week

Exclusion Criteria:
  • With implanted devices

  • Not having clear consciousness

  • Expected life span less than 1 week

  • Foreigner

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taipei Veterans General Hospital Taipei Taiwan 11217

Sponsors and Collaborators

  • Taipei Veterans General Hospital, Taiwan

Investigators

  • Principal Investigator: Shinn-Jang Hwang, MD, Taipei Veterans General Hospital, Taipei, Taiwan

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Taipei Veterans General Hospital, Taiwan
ClinicalTrials.gov Identifier:
NCT02663063
Other Study ID Numbers:
  • 2015-10-005A
First Posted:
Jan 26, 2016
Last Update Posted:
Feb 2, 2016
Last Verified:
Jan 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Taipei Veterans General Hospital, Taiwan

Study Results

No Results Posted as of Feb 2, 2016